Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
RIGL
RIGL
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
RIGL News
Rigel Pharmaceuticals to Present at Jefferies Global Healthcare Conference
6d ago
PRnewswire
Rigel Pharmaceuticals Presents GAVRETO Phase 3 Data at ASCO 2026
May 21 2026
PRnewswire
Rigel Pharmaceuticals to Present GAVRETO and REZLIDHIA Data at ASCO Annual Meeting
May 21 2026
Newsfilter
Rigel Pharmaceuticals to Present at RBC Capital Markets Global Healthcare Conference
May 14 2026
PRnewswire
Rigel Partners with Arvinas and Pfizer for Breast Cancer Treatment
May 12 2026
stocktwits
Arvinas and Rigel Reach Licensing Agreement for Breast Cancer Therapy
May 12 2026
seekingalpha
Rigel Pharmaceuticals Q1 2026 Earnings Call Insights
May 06 2026
seekingalpha
Rigel Pharmaceuticals Reports Q1 Earnings Decline
May 06 2026
NASDAQ.COM
Rigel Pharmaceuticals Q1 Earnings Miss Expectations
May 05 2026
seekingalpha
Rigel Pharmaceuticals to Report Q1 2026 Financial Results
Apr 28 2026
PRnewswire
Eli Lilly Ends Collaboration with Rigel on Ocadusertib
Apr 21 2026
seekingalpha
Rigel Pharmaceuticals Grants Restricted Stock Units to Employees
Apr 07 2026
PRnewswire
CytomX Therapeutics Stock Surges 44.23% Following Positive Phase 1 Data
Mar 16 2026
Fool
CytomX Therapeutics Stock Soars 44.23% After Positive Phase 1 Data
Mar 16 2026
NASDAQ.COM
CytomX Therapeutics Stock Soars 44.23% After Positive Phase 1 Data
Mar 16 2026
Yahoo Finance
Rigel Pharmaceuticals Shares Hit Four-Month Low Amid Revenue Decline Projections
Mar 04 2026
seekingalpha
Show More News
